Literature DB >> 9430756

Spectral properties of fricatives in amyotrophic lateral sclerosis.

K Tjaden1, G S Turner.   

Abstract

Spectral characteristics of word initial /s/ and "sh" produced by individuals with amyotrophic lateral sclerosis (ALS) and healthy controls were quantified using spectral moment analysis. Coefficients of the first four moments were used as descriptive indices of central tendency, spread of energy, shape, and peakedness. The relationship between select moment coefficients and consonant precision ratings was investigated to explore potential perceptual correlates of the acoustic measures. To examine whether spectra for ALS and healthy speakers were influenced similarly by context, first moment coefficients for three occurrences of /s/ in "some" were inspected for individual speakers. Select moment coefficients also were compared to hand-derived spectral measures for a subset of speakers. Results suggest articulatory differences in /s/ and "sh" for the present group of ALS speakers and healthy controls, as indexed by between-group differences in first moment coefficients. A linear function accounted for a significant proportion of the variance in the relationship between consonant precision ratings and the frequency difference between the first moment for /s/ and "sh". Inspection of first moment coefficients for multiple occurrences of /s/ in "some" suggests context influences the first moment in a similar manner for ALS and healthy speakers. The subanalysis comparing moment coefficients and hand-derived spectral measures revealed both similarities and differences in the manner the two measurement techniques reflect spectral shape.

Entities:  

Mesh:

Year:  1997        PMID: 9430756     DOI: 10.1044/jslhr.4006.1358

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  13 in total

1.  Evaluating the spectral distinction between sibilant fricatives through a speaker-centered approach.

Authors:  Katarina L Haley; Elizabeth Seelinger; Kerry Callahan Mandulak; David J Zajac
Journal:  J Phon       Date:  2010-10-01

2.  New and old directions.

Authors:  Frank Buckley
Journal:  Downs Syndr Res Pract       Date:  2007-07

3.  Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.

Authors:  Kris Tjaden; Jennifer Lam; Greg Wilding
Journal:  J Speech Lang Hear Res       Date:  2013-07-09       Impact factor: 2.297

4.  Spatiotemporal coupling of the tongue in amyotrophic lateral sclerosis.

Authors:  Mili S Kuruvilla; Jordan R Green; Yana Yunusova; Kathy Hanford
Journal:  J Speech Lang Hear Res       Date:  2012-05-21       Impact factor: 2.297

5.  Measures to Evaluate the Effects of DBS on Speech Production.

Authors:  Gary Weismer; Yana Yunusova; Kate Bunton
Journal:  J Neurolinguistics       Date:  2012-03       Impact factor: 1.710

6.  Age-Related Changes in Speech and Voice: Spectral and Cepstral Measures.

Authors:  Sammi Taylor; Christopher Dromey; Shawn L Nissen; Kristine Tanner; Dennis Eggett; Kim Corbin-Lewis
Journal:  J Speech Lang Hear Res       Date:  2020-02-25       Impact factor: 2.297

7.  Speech and Swallowing in Parkinson's Disease.

Authors:  Kris Tjaden
Journal:  Top Geriatr Rehabil       Date:  2008

8.  Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.

Authors:  Lynda Feenaughty; Kris Tjaden; Joan Sussman
Journal:  Clin Linguist Phon       Date:  2014-05-29       Impact factor: 1.346

9.  Kinematics of disease progression in bulbar ALS.

Authors:  Yana Yunusova; Jordan R Green; Mary J Lindstrom; Laura J Ball; Gary L Pattee; Lorne Zinman
Journal:  J Commun Disord       Date:  2009-07-24       Impact factor: 2.288

10.  Toward improved spectral measures of /s/: results from adolescents.

Authors:  Laura L Koenig; Christine H Shadle; Jonathan L Preston; Christine R Mooshammer
Journal:  J Speech Lang Hear Res       Date:  2013-06-19       Impact factor: 2.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.